The Consortium of Multiple Sclerosis Centers Annual Meeting will present the latest topics in MS research and treatment May 28-June 1.
The latest research in multiple sclerosis (MS), along with the most recent advancements in treatment strategies and comprehensive care, will be presented at the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, which beings today.
Running through June 1 at the Washington State Convention Center in Seattle, the meeting program, which is geared toward MS healthcare professionals, will include opening lectures, panel discussions mediated by experts, and education programs for physicians, physician assistants, nurses, pharmacists, social workers, mental health and rehabilitation professionals.
“This year’s lectures feature some of the leading authorities in MS care and research,’ June Halper, CEO at CMSC, said in a press release.
“The world of MS diagnosis, treatment and care is evolving and attendees at the CMSC Annual Meeting will be immersed in the latest care strategies and research findings that lead to optimal outcomes for patients,” Halper added.
The CMSC Annual Meeting is the only one in North America focusing on healthcare professionals to bring the latest advancements related to MS.
Opening the CMSC meeting will be James D. Bowen, MD, medical director of the Multiple Sclerosis Center at Seattle’s Swedish Neuroscience Institute with a talk titled, “Mountains to Climb: The Cause, Treatment and Care of MS in the Pacific Northwest.” Bowen will discuss the challenges in creating regional systems of MS care in the Pacific Northwest, but also will share cases of success.
On Wednesday, May 29, Bruce D. Trapp, PhD, a lead researcher at the Cleveland Clinic’s Lerner Research Institute, will deliver the John F. Kurtzke Memorial Lecture in a presentation titled “A Novel Subtype of Multiple Sclerosis.”
Trapp and colleagues found a new MS subtype — called myelocortical MS (MCMS) — that is characterized by cortical neuronal loss, but not by loss of myelin in the brain’s white matter, according to a study. In this talk, Trapp will discuss the significance of those findings, and what clinicians need to know about this new MS subtype.
|Read on: Experts Gather for Consortium of Multiple Sclerosis Centers Meeting|